FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aristo Bio-Tech and Lifescience IPO and Chaman Metallics IPO.
Aristo Bio-Tech and Lifescience IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Chaman Metallics IPO is a SME Fixed Price Issue proposed to list at NSE SME.
Aristo Bio-Tech and Lifescience IPO | Chaman Metallics IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Beeline Capital Advisors Pvt Ltd | Hem Securities Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | Sunflower Broking Private Limited | Hem Finlease Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aristo Bio-Tech and Lifescience IPO is up to ₹13.05 Cr whereas the issue size of the Chaman Metallics IPO is up to ₹24.21 Cr. The final issue price of Aristo Bio-Tech and Lifescience IPO is ₹72.00 per share and of Chaman Metallics IPO is ₹38.00 per share.
Aristo Bio-Tech and Lifescience IPO | Chaman Metallics IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹72.00 per share | ₹38.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 3000 shares |
Fresh Issue Size | 18,12,800 shares | 63,72,000 shares |
Fresh Issue Size (Amount) | up to ₹13.05 Cr | up to ₹24.21 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 18,12,800 shares | 63,72,000 shares |
Issue Size Total (Amount) | up to ₹13.05 Cr | up to ₹24.21 Cr |
Aristo Bio-Tech and Lifescience IPO opens on Jan 16, 2023, while Chaman Metallics IPO opens on Jan 04, 2023. The closing date of Aristo Bio-Tech and Lifescience IPO and Chaman Metallics IPO is Jan 19, 2023, and Jan 06, 2023, respectively.
Aristo Bio-Tech and Lifescience IPO | Chaman Metallics IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jan 16, 2023 | Jan 04, 2023 |
Issue Close | Jan 19, 2023 | Jan 06, 2023 |
Basis Of Allotment (Tentative) | Jan 24, 2023 | Jan 11, 2023 |
Initiation of Refunds (Tentative) | Jan 25, 2023 | Jan 12, 2023 |
Credit of Share (Tentative) | Jan 27, 2023 | Jan 13, 2023 |
Listing date (Tentative) | Jan 30, 2023 | Jan 16, 2023 |
Anchor Lockin End date 1 | Feb 23, 2023 | Feb 10, 2023 |
Anchor Lockin End date 2 | Apr 24, 2023 | Apr 11, 2023 |
Aristo Bio-Tech and Lifescience IPO P/E ratio is 9.46, as compared to Chaman Metallics IPO P/E ratio of 6.73.
Aristo Bio-Tech and Lifescience IPO | Chaman Metallics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100.00% | 100.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.37% | 73.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 9.46 | 6.73 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹49.02 Cr. | ₹91.71 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Aristo Bio-Tech and Lifescience IPO retail investors (RII) are offered 8,60,800 shares while in Chaman Metallics IPO retail investors are offered 8,60,800 shares. Qualified institutional buyers (QIB) are offered in Aristo Bio-Tech and Lifescience IPO and in Chaman Metallics IPO.
Aristo Bio-Tech and Lifescience IPO | Chaman Metallics IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 91,200 shares | 3,24,000 shares |
QIB | ||
NII | 8,60,800 shares | 30,24,000 shares |
RII | 8,60,800 shares | 30,24,000 shares |
Employee | ||
Others | ||
Total | 17,21,600 shares | 60,48,000 shares |
Aristo Bio-Tech and Lifescience IPO subscribed 217.72x in total, whereas Chaman Metallics IPO subscribed 207.88x.
Aristo Bio-Tech and Lifescience IPO | Chaman Metallics IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 285.84x | 255.92x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 149.59x | 159.85x |
Employee (times) | ||
Other (times) | ||
Total (times) | 217.72x | 207.88x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|